Filter Results:
(91)
Show Results For
- All HBS Web
(91)
- News (16)
- Research (57)
- Events (1)
- Multimedia (1)
- Faculty Publications (37)
Show Results For
- All HBS Web
(91)
- News (16)
- Research (57)
- Events (1)
- Multimedia (1)
- Faculty Publications (37)
- March 2015
- Teaching Note
CVS Health: Promoting Drug Adherence
Email mking@hbs.edu for a courtesy copy.
This Teaching Note explains the theory of the case and teaching plan for the case: CVS Health: Promoting Drug Adherence (515010). The case finds Helena Foulkes, Executive... View Details
This Teaching Note explains the theory of the case and teaching plan for the case: CVS Health: Promoting Drug Adherence (515010). The case finds Helena Foulkes, Executive... View Details
Keywords: Medication Adherence; Affordable Care Act (ACA); Marketing Strategy; Communication Strategy; Customer Value and Value Chain; Decisions; Health Care and Treatment; Goals and Objectives; Resource Allocation; Marketing Communications; Consumer Behavior; Measurement and Metrics; Service Delivery; Behavior; Motivation and Incentives; Social Issues; Information Technology; Value Creation; Health Industry; Pharmaceutical Industry; Insurance Industry; Public Relations Industry; Retail Industry; United States
John, Leslie, John Quelch, and Robert Huckman. "CVS Health: Promoting Drug Adherence." Harvard Business School Teaching Note 515-086, March 2015. (Email mking@hbs.edu for a courtesy copy.)
- 09 Aug 2016
- First Look
August 9, 2016
when launching a new technology venture, the strategic complexities of multi-layer distribution channels, difficulties attaining reimbursement from third-party payers (particularly Medicare), and valuation issues when significant capital... View Details
Keywords: Sean Silverthorne
- 04 Oct 2019
- HBS Seminar
Annabelle Fowler (Harvard University), Harvard University
- November 2023 (Revised April 2024)
- Case
BiomX: Bringing Phage Back to the Stage
By: Paul A. Gompers, Elie Ofek, Orna Dan and Emilie Billaud
In the spring of 2023, and following the favorable results of a trial involving its phage cocktail for treating lung infections among cystic fibrosis (CF) patients, the leadership of BiomX had several critical issues to wrestle with. First, given its precarious... View Details
Keywords: Working Capital; Financing and Loans; Health Testing and Trials; Product Development; Research and Development; Science-Based Business; Commercialization; Biotechnology Industry; Pharmaceutical Industry
Gompers, Paul A., Elie Ofek, Orna Dan, and Emilie Billaud. "BiomX: Bringing Phage Back to the Stage." Harvard Business School Case 524-051, November 2023. (Revised April 2024.)
- Program
Managing Health Care Delivery
reform, and payers are demanding cost control. These factors have placed great strain on health care delivery, and pose significant challenges for vulnerable populations. These issues are not unique; they are systemic factors that... View Details
- Article
Health App Policy: International Comparison of Nine Countries' Approaches
By: Anna Essén, Ariel Dora Stern, Christoffer Bjerre Haase, Josip Car, Felix Greaves, Dragana Paparova, Steven Vandeput, Rik Wehrens and David W. Bates
An abundant and growing supply of digital health applications (apps) exists in the commercial tech-sector, which can be bewildering for clinicians, patients, and payers. A growing challenge for the health care system is therefore to facilitate the identification of... View Details
Keywords: Digital Health; Apps; Health Care and Treatment; Internet and the Web; Policy; Global Range; Applications and Software
Essén, Anna, Ariel Dora Stern, Christoffer Bjerre Haase, Josip Car, Felix Greaves, Dragana Paparova, Steven Vandeput, Rik Wehrens, and David W. Bates. "Health App Policy: International Comparison of Nine Countries' Approaches." npj Digital Medicine 5, no. 31 (2022).
- September 2017 (Revised February 2023)
- Case
Intermountain Healthcare: Pursuing Precision Medicine
By: Richard G. Hamermesh, Kathy E. Giusti, Robert S. Huckman and Julia Kelley
Headquartered in Salt Lake City, Intermountain Healthcare operates 23 hospitals and hundreds of clinics in Utah and Idaho and provides insurance to approximately 850,000 patients through its insurance arm, SelectHealth. In 2013, Intermountain, known for its commitment... View Details
Keywords: Precision Medicine; Healthcare; Innovation; Cancer; Cancer Research; Health Care; Technology; Health Care and Treatment; Innovation Leadership; Disruptive Innovation; Entrepreneurship; Decision Choices and Conditions; Health Industry; Insurance Industry; Utah; United States; North America
Hamermesh, Richard G., Kathy E. Giusti, Robert S. Huckman, and Julia Kelley. "Intermountain Healthcare: Pursuing Precision Medicine." Harvard Business School Case 818-018, September 2017. (Revised February 2023.)
- Web
Aligning Reimbursement with Value - Institute For Strategy And Competitiveness
lead to both outcomes and cost improvement. In addition to CMS bundles, pilot programs with insurers such as UnitedHealthcare and with employers such as Walmart, are creating opportunities for both providers and payers to create... View Details
- Web
Measure Outcomes & Cost for Every Patient - Institute For Strategy And Competitiveness
begins locally with involved providers in a non-judgmental manner. Over time, reporting can be expanded to other providers and payers. Public reporting can lead to informed patient and payer choice in the selection of providers. Current... View Details
- Web
Academics - Health Care
how strategic principles can be applied in health care settings to identify sources of competitive advantage (and all too often, disadvantage). Our emphasis will be on payers and providers, but we will also devote 20-25% of our case... View Details
- Web
Information Technology - Institute For Strategy And Competitiveness
activity-based costing measures for each patient and medical condition. Adopt interoperability standards enabling communication among different provider and payer organizations as part of a larger restructuring effort; eliminate expensive... View Details
- Web
Understanding Health Systems, Payors, and Regulation - Health Care
Teisberg. Competition and the Intersection of Industry and Policy is at the heart of Professor Leemore Dafny’s research which examines competitive interactions among payers and providers of health care services. Her current projects... View Details
- 2024
- Working Paper
Does Private Equity Have Any Business Being in the Health Care Business?
By: Nori Gerardo Lietz and Zirui Song
Private Equity (“PE”) has come under increased scrutiny by the press, academics, and policymakers, as well as the public, for its investments in health care delivery. This scrutiny has been exacerbated by recent high profile hospital bankruptcies following PE... View Details
Lietz, Nori Gerardo, and Zirui Song. "Does Private Equity Have Any Business Being in the Health Care Business?" Harvard Business School Working Paper, No. 25-012, September 2024.
- 31 Mar 2023
- Research & Ideas
Can a ‘Basic Bundle’ of Health Insurance Cure Coverage Gaps and Spur Innovation?
would make payments to health care providers on a risk-adjusted per-enrolled basis instead of a fee-for-service basis—as a tool to mitigate risks involved with centralized pricing and rate-setting. Evidence suggests that capitation can drive View Details
- 22 Aug 2022
- Research & Ideas
Can Amazon Remake Health Care?
First, the supply chain in health care is a mess. There are so many intermediaries selling to other people, and Amazon has done extremely well by streamlining the supply chain. So they must be thinking that the current insurers and other View Details
- Web
Frequently Asked Questions | HBS Online
allow a Third Party to pay on their behalf, using the Third-Party payment feature. Additionally, a Third-Party payer can be added as an authorized payer permitting HBS Online to communicate with the... View Details
- 12 Jul 2004
- Research & Ideas
Michael Porter’s Prescription For the High Cost of Health Care
becomes the engine of progress and reform. Improvement feeds on itself. For that process to begin, however, the locus of competition has to shift from "Who pays?" to "Who provides the best value?" Getting there will require changes in the strategies... View Details
- Career Coach
Johnny Weger
Johnny has been deeply embedded in healthcare strategy from a variety of angles and enjoys assisting students who are interested in providers and payers (incumbents as well as disruptors). He is particularly well-equipped to help students... View Details
Gil Addo
firms and in 2021 was acquired by Oak Street Health for $190 million. Prior to founding RubiconMD, Gil was a Consultant at Putnam Associates, a pharma strategy consultancy, where he designed payer and market access strategies for fortune... View Details
Keywords: Digital Health
Gil Addo
firms and in 2021 was acquired by Oak Street Health for $190 million. Prior to founding RubiconMD, Gil was a Consultant at Putnam Associates, a pharma strategy consultancy, where he designed payer and market access strategies for fortune... View Details
Keywords: Healthcare